Hafrun Fridriksdottir
President, Generics
2024 Appointed
2024 Joined Hikma
Icelandic Nationality
Role: Hafrun joined Hikma in April 2024 as President of Hikma’s Generics business. Prior to joining Hikma, Hafrun held senior executive roles at leading global pharmaceutical companies including Alvotech, Teva Pharmaceuticals, Allergan and Actavis, and most recently has served in advisory and board roles for several biotech and mid-sized pharma companies.
Qualifications: MS Degree in Pharmacy and a PhD in Physical Pharmacy from the University of Iceland.